Mirabilis jalapa L. leave has been reported to contain Ribosome-inactivating protein (RIP), which demonstrated to have in vitro cytotoxic effect on cancer cell lines and prevention effect against skin cancer. This research examined the therapeutic effect of protein fraction containing RIP isolated from Mirabilis jalapa L. (MJ protein) against skin cancer.
INTRODUCTION
Ribosome-Inactivating Proteins (RIP) are protein toxins that have N-glycosidase activity to inhibit the protein synthesis by inactivating ribosomes through the cleaving of the N-glycosidic bond at the A4324 position of 28S RNA, so that they are no longer able to function in [1] [2] protein synthesis . The term RIP was used exclusively for N-glycosidase because other types of proteins that inactivate or damage ribosomes by other mechanisms 3 (e.g., RNases or proteases) are not considered as RIP . This protein receives a lot of attention in biomedical research because of their unique biological activities toward animal and human cells. Choudhary and 4 colleagues (2008) reviewed that recombinant RIPs have also been found to possess a number of enzymatic 5 properties, such as antiviral , RNase activity and 6 depurination of capped mRNAs .
Mirabilis jalapa L. leave has been reported to contain Ribosome-inactivating protein (RIP) cleaving single was isolated, called MJ proteins. Further purication of this protein using ion exchange chromatography resulted in 2 active RIPs with the molecular weight of aproximately 30kD, they are MJ-30 protein, a basic RIP 8 and MJ-C, an acidic RIP . The MJ-30 protein was reported to have an in vitro cytotoxic effect on HeLa cell- 9 10 line and SiHa cell line , with the IC of 91μg/ml and 5.6 50 μg/ml, respectively. Whereas the MJ-C was cytotoxic on HeLa, Myeloma and T47D cell lines, with the IC of 14.3 50 11 μg/ml, 7.4 μg/ml, and 27.8 μg/ml, respectively . UV spectrophotometer .
Cleavage of supercoiled DNA by MJ protein
Two microgram of supercoiled double stranded plasmid DNA (pUC18) was incubated with 6 µg of MJ protein to a nal volume of 10 μl in mixed of 50 mM Tris-HCl, 10 mM MgCl2, 100 mM NaCl, pH 8.0, at room temperature for 1 hour. At the end of the reaction, 3 μl of loading buffer (30% glycerol, 200 mM EDTA, 0.25% bromophenol blue a n d 0 . 2 5 % x y l e n e c y a n o l F F ) w e r e a d d e d . Electrophoresis was carried out using a 0.8% agarose gel (containing ethidium bromide) in TBE (tris-borat) 14 buffer. DNA bands were visualized by using UV lamp .
Induction of skin cancer
To induce the skin cancer, BALB/c mice were topically exposed to single dose of 0.2mg/0,1mL 9,10-dimethylbenz[α]anthracene (DMBA) and UVB radiation 2 (daily dose, 0.4 J/cm ) for 60 days. After the induction, two mice were randomly collected and sacried (named post UVB control sample). Mid-dorsal skin of mice were 15 excised and xed in 10 % buffer formalin .
Therapy of the skin cancer and handling of the mice
Mice were divided into ve groups: normal skin control group (15 mice), UVB control/untreated group (10 mice), phosphate buffer control group (20 mice), treated with 0.3mg/0.1 ml of MJ protein group (20 mice), and treated with 1.2mg/0.1 ml of MJ protein group (20 mice). MJ protein was applied to the dorsum of mice induced by DMBA co-carcinogen and UVB sixty times in 10 weeks. DMSO was used before MJ protein application to enhance the permeation of MJ protein. Tumor incidence and tumor multiplicity were observed every day. Tumor incidence is percentage of nodule-possessing mice in a group. Tumor multiplicity is total of nodules in a group per total of mice in a group.
To collect the skin samples, 2-3 mice from each treatment group were sacried at 6 and 10 weeks of therapy. Mid-dorsal skin of mice were excised, stored in a formalin solution, and parafn embedded. Subsequently, tissue sections were cut at 3-4 µm onto poly-L-lysine coated slides. For histological analysis, deparafnized sections were subsequently stained with haematoxylin and eosin, and immunohistochemically 15 stained for bcl2 .
Identication of bcl2 protein using immunohistochemistry technique
The tissue sections were de-parafnized and subsequently washed with PBS (three times, each for 5 minutes). Endogenous peroxidase was quenched by incubation of tissue in 3% (v/v) of hydrogen peroxide in methanol for 20 minutes and then washed with aquadest and PBS (each of them: for 5 minutes). Citric acid buffer (pH 6.0) and microwave treatment (for 10 minutes) were used for antigen retrieval. Subsequently, the tissue sections were incubated with normal mice serum (1:50) for 5 minutes. After removing of normal mice serum (without washing), bcl2 antibody was applied onto each tissue section (1:100 dilution) at 4°C for 60 minutes. The antibody used was able to recognize wild type and bcl2 mutant. Subsequently, the tissue sections were incubated at room temperature for 5 minutes with biotinylated anti-mouse IgG and then washed with PBS for 5 minutes). Finally, the immunoreactions were visualized using Streptavidinperoxidase complexes for 10 minutes and the peroxidase reaction was developed in 3,3'-diaminobenzidine chromogen. Tissue sections were counterstained with haematoxylin for 3-4 seconds, followed by dehydration through graded ethanol solutions and then mounted (standard procedure of Pathology and Anatomy Laboratory Sardjito Hospital). Any statistical analysis was carried out using one way analysis of variance (ANOVA) with SPSS software. The signicance level was set at 0.05.
RESULTS AND DISCUSSION
Cleavage of supercoiled DNA by MJ protein RIP is a toxic protein that inhibits protein synthesis. This activity is believed due to an N-glycosidase activity. In additional to this activity, several RIPs also demonstrated unique enzymatic activity of cleaving double 14 stranded DNA into nicked circular or linier forms . In this experiment, activity test on cleaving supercoiled DNA (puC18) was carried out (as described in the methodology) in order to prove the presence of RIPs in the MJ protein isolated from M. jalapa L (Figure 1 ).
It was demonstrated that the supercoiled DNA band (a) and nicked circular DNA band (c1) appeared at untreated pUC18 (lane 1). At the MJ protein application (lane 2), the supercoiled DNA band (a) disappeared, while linear DNA band (b) appeared, and nicked circular 
Skin cancer induced by DMBA application and UV radiation to mouse skin
The results of cancer induction showed that tumor nodule started to appear after 18 times of UVB exposure, and subsequently followed by other mice at the next exposure. After 60 times of UVB exposure, the percentage of tumor incidence was 77%, while there was no mice from the control group showing tumor nodule. The differences of time needed by mice (among UVB exposure group) to show tumor nodule might be caused by genetic polymorphism, differences in immunological response and antioxidant defense 16 system , and health condition. DMBA single dose and UVB radiation were used to induce the skin cancer because a previous study showed that combination of these carcinogens was more effective than UVB 15 exposure only .
Effect of MJ protein towards tumor incidence and multiplicity
The results showed that the therapeutic effect did not show a consistent result at 4 weeks of therapy. However, there was an inclination of tumor incidence decreased on dose of 0.3 mg/0.1 ml, while dose of 1.2 mg/0.1 ml did not show the decrease of tumor incidence. The effect of MJ protein at both doses (0.3 mg/ml and 1.2 mg/0.1ml) towards the decrease of tumor incidence started to appear at 5 weeks of therapy and continued till 10 weeks of therapy (Figure 2 ). MJ protein-treated group showed the decrease of tumor incidence by 26 to 38% at 10 weeks of therapy. The MJ protein seemed to be more effective for a preventive effects as indicated by decrease the skin tumor incidence by 50% at the dose of 17 1.2 mg/0.1 ml .
Fig. 2: The decrease of tumor incidence caused by MJ protein
Besides observing the tumor incidence, this study also observed the growth of tumor nodule shown in tumor multiplicity. The results showed that MJ protein (doses of 0.3 mg/0.1 ml and 1.2 mg/0.1 ml) was able to decrease the tumor multiplicity. The decrease of tumor multiplicity started to appear at 5 weeks of therapy and continued till 10 weeks of therapy ( Figure 3 ).
Fig. 3: The Decrease of Tumor Multiplicity caused by MJ protein
Tumor nodule regression was also observed with two parameters, namely (1) the rate and amount of mice which was free from nodule tumor, and (2) the diameter of tumor nodule. In the rst parameter, the results showed that 12.5% of untreated group (UVB control group) was free from tumor nodule at 10 weeks of therapy, while each of treated group (0.3 mg/0.1 ml and 1.2 mg/0.1 ml) showed amount of mice which is free from tumor nodule by 35.3% at 8 weeks of therapy ( Figure 4) . It means that the tumor nodule regression of MJ protein-treated group was two weeks faster than untreated group. Subsequently, the percentage of the mice which is free from tumor nodule in treated group was more than untreated group.
The second parameter of tumor nodule regression was the decrease of nodule diameter. The group 5 (dose of 1.2 mg/0.1 ml) showed the mean decrease of nodule diameter by 17.36%, while the group 4 (dose of 0.3 mg/0.1 ml) showed the mean increase of nodule diameter (not shown).
The skin cancer types which appeared in this experiment were: papilloma, squamous cell carcinoma (SCC) and broma. Papilloma and broma are benign tumor at epithelial layer and brous connective tissue, respectively, while SCC is malignant tumor. This experiment showed that MJ protein therapy (doses of 0.3 mg/0.1 ml and 1.2 mg/0.1 mL) was able to decrease the incidence of skin cancer (SCC) by 75.5%.
Effect of MJ protein towards bcl2 protein expression
As shown in Figure 5 , the expression of bcl2 protein (epidermal cells expressing bcl2 proteins had brown membrane and cytoplasm), the anti-apoptotic protein, in the group treated with the dose of 0.3 mg/0.1 ml and 1.2 mg/0.1 ml MJ protein was signicantly decreased at 82.38% and 78.40% compared to post UVB control sample (10 weeks of therapy). However, there was no signicant difference (p > 0.05) among the dose groups. On the other hand, the expression bcl2 protein in the group treated with phosphate buffer was decreased at 15.87% compared to post UVB control sample. This result supported the previous nding that protein containing RIPs was able to induce the p53 expression 18 and decrease the bcl2 expression on cancer cell lines . Based on all these nding, MJ protein become a potent candidate for cancer therapy and prevention, especially when it could be formulated as nanoparticles, such as using chitosan. Recently, nanoparticle for drug formulation become interesting since this formula could protect the drug in the systemic circulation, so that could increase therapeutic benet and minimizing the side- 25, 26 effects . The mechanisms by which MJ protein decreased the expression of bcl2 protein on skin cancer therapy need to be investigated further.
CONCLUSION
MJ protein therapy was able to decrease the incidence of skin cancer (SCC) by 75.5% and tumor nodul regression (approximately 35.3%) at 10 weeks of therapy. It was also able to decrease the tumor nodul diameter by 17.36%. In addition, using 95% of condence level, MJ protein was able to signicantly decrease (p > 0.05) the expressions of bcl2 protein at 82.38% and 78.40% compared to post UVB control sample (10 weeks of therapy).
